Welcome to the Department of Oncology
Department of Oncology is located at two sites, The Norwegian Radiumhospital and Ullevål. The department is constantly carrying out intensive research on new cancer treatment methods.
The development of new treatments are initially taking place in laboratories by experimenting on isolated cells, tissue and in animal models. Drugs showing promising activities in the model systems are then tested out thoroughly in clinical studies on patients with cancer. A large number of the patients in the department are participating in various clinical studies.
Cancer Treatment Programmes
The hospital activity is organized according to Treatment Programmes. Each treatment program organize their own research activity. Within the department there is also a Section for Clinical Cancer Research and Resource Development. Part of this section offers administrative support, organizes research nurses and project managers.
Clinical research on new therapies and procedures in human beings is often time consuming and difficult to carry out at an ordinary hospital ward. The Department of Oncology therefore established its Clinical Cancer Research Unit with its own doctors, project managers and specially trained nurses for early drug development (phase I and II studies).
| Cancer Treatment Programmes: |
| Breast cancer |
| Gynaecological cancer (choriocarcinoma, cervical cancer, ovarial cancer, vulva cancer) |
| Head & neck cancer |
| Lung cancer |
| Lymphoma |
| Sarcoma |
| CNS tumors and eye cancer |
| Colorectal, upper GI and anal cancer |
| Malignant melanomas, skin tumores |
| Testicular, bladder/penis and prostate cancer |
| Thyoroidal cancer |
Latest publications
Department of Oncology
Hypoxic Tumor Kinase Signaling Mediated by STAT5A in Development of Castration-Resistant Prostate Cancer
PLoS One, 8 (5), e63723
PubMed 23675504
Does in-house availability of multidisciplinary teams increase survival in upper gastrointestinal-cancer?
World J Gastrointest Oncol, 5 (3), 60-7
PubMed 23671732
Novel molecular tumor cell markers in regional lymph nodes and blood samples from patients undergoing surgery for non-small cell lung cancer
PLoS One, 8 (5), e62153
PubMed 23671585





Print this page
